Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Circulatory system drugs >  Antihypertensive drugs >  3-Bromo-1,3,4,5-tetrahydro-2H-benzo[b]azepin-2-one

3-Bromo-1,3,4,5-tetrahydro-2H-benzo[b]azepin-2-one

Basic information Safety Supplier Related

3-Bromo-1,3,4,5-tetrahydro-2H-benzo[b]azepin-2-one Basic information

Product Name:
3-Bromo-1,3,4,5-tetrahydro-2H-benzo[b]azepin-2-one
Synonyms:
  • Intermediate 3-Bromo-2,3,4,5-tetrahydro-2H-benzo[b]azepin-2-one
  • 3-bromo-1,3,4,5-tetrahydro-2H-1-benzoazepine-2-one
  • 3-bromo-1,3,4,5-tetrahydro-1-benzazepin-2-one
  • 3-bromo-1,3,4,5-tetrahydro-2H-1-benzoazepine-2-on
  • A-BROMOBENZOCAPROLACTAM
  • ALPHA-BROMOBENZO-CAPROLACTAM
  • 3-Bromobenzocaprolactam 3-Bromo-2,3,4,5-tetrahydro-2H-benzo[b]azepin-2-one
  • 3-Bromo-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one
CAS:
86499-96-9
MF:
C10H10BrNO
MW:
240.1
EINECS:
617-868-7
Product Categories:
  • pharmacetical
  • 86499-96-9
  • john's
Mol File:
86499-96-9.mol
More
Less

3-Bromo-1,3,4,5-tetrahydro-2H-benzo[b]azepin-2-one Chemical Properties

Melting point:
164 °C
Boiling point:
383.2±42.0 °C(Predicted)
Density 
1.492±0.06 g/cm3(Predicted)
Flash point:
185.542℃
storage temp. 
Keep in dark place,Sealed in dry,Room Temperature
solubility 
slightly soluble in ethanol, benzene, acetone, insoluble in water
pka
13.59±0.40(Predicted)
Appearance
Off-white to light yellow Solid
InChI
InChI=1S/C10H10BrNO/c11-8-6-5-7-3-1-2-4-9(7)12-10(8)13/h1-4,8H,5-6H2,(H,12,13)
InChIKey
JMXPGCGROVEPID-UHFFFAOYSA-N
SMILES
N1C2=CC=CC=C2CCC(Br)C1=O
CAS DataBase Reference
86499-96-9(CAS DataBase Reference)
More
Less

3-Bromo-1,3,4,5-tetrahydro-2H-benzo[b]azepin-2-one Usage And Synthesis

Uses

3-Bromo-1,3,4,5-tetrahydro-2H-benzo[b]azepin-2-one is an intermediate in the synthesis of Benazepril Hydrochloride. Benazepril Hydrochloride is a first-line antihypertensive drug recommended by the WHO. It is a chiral drug with excellent clinical efficacy, strong safety and tiny side effects in the international antihypertensive drugs of angiotensin converting enzyme inhibitors.

Chemical Properties

White or almost white crystalline

Preparation

The preparation of 3-Bromo-1,3,4,5-tetrahydro-2H-benzo[b]azepin-2-one is as follows:10 parts by weight of the heated melted polyphosphoric acid was added to the drying kettle, With stirring, The above 2-bromo-3,4-dihydro-N-hydroxy- (2H) -naphthalimide was added in portions at a temperature of 60 ° C, Insulation reaction for 20 hours; The reaction solution was added dropwise to 12.5 parts by weight of water to carry out hydrolysis, Still Washed to give 3-bromo-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one crude; 10 parts by weight of methanol and 0.1 part by weight of activated carbon were added, Heating decolorization, After filtration, the filtrate was cooled to 10 ° C for 20 hours, centrifuged, washed and dried to give 3-bromo-1,3,4,5-tetrahydro-2H-1-benzazepan-2-one. The purity of the product was 3, 10-bromo-1,3,4,5-tetrahydro-2H-1-benzazepan-2-one as high as 99.6% and the yield was as high as 98%.

Synthesis

4424-80-0

86499-96-9

General procedure for the synthesis of 3-bromo-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one from 1,3,4,5-tetrahydro-2H-1-benzazepin-2-one: 1,3,4,5-tetrahydro-2H-1-benzazepin-2-one (1.0 g, 6.20 mmol) was dissolved in anhydrous CHCl3 (15 ml) and cooled to 0 °C ( ice-salt bath). Under argon protection, PCl5 (1.5 g, 7.20 mmol) and I2 (15 mg) were added and stirred at 0 °C for 30 min. Subsequently, Br2 (0.39 ml, 7.51 mmol) was added dropwise to the reaction solution, which was slowly warmed to room temperature and refluxed for 4.0 h under argon protection. After completion of the reaction, the mixture was poured into ice water (20 g) and the organic and aqueous phases were separated after thorough stirring. The aqueous phase was extracted with CHCl3 (25 ml), the organic phases were combined, washed with H2O (5.0 ml), dried over anhydrous MgSO4, filtered and concentrated to dryness, and dried under vacuum to give the crude product. The crude product was purified by silica gel column chromatography (Merck, 70 g) with EtOAc: hexane (1:9) as eluent to afford 3-bromo-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one as an off-white solid (1.137 g, 70.1% yield, melting point 170-172 °C). The structure of the product was confirmed by 1H-NMR and 13C-NMR. TLC detection: Rf 0.13 (silica gel plate, EtOAc:hexane=1:4, observed under UV light).

References

[1] Patent: US6777550, 2004, B1. Location in patent: Page column 28
[2] Patent: US4575503, 1986, A
[3] Patent: US4410520, 1983, A
[4] Patent: US4473575, 1984, A
[5] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 17, p. 3488 - 3494

3-Bromo-1,3,4,5-tetrahydro-2H-benzo[b]azepin-2-oneSupplier

Harway Pharma CO., LTD Gold
Tel
0546-5612566 13793982289
Email
lucy@harwaypharma.com
AstaTech(Chengdu) Biopharmaceutical Corp. Gold
Tel
028-82666846 18080826311
Email
sales@astatech.com.cn
Zhejiang Karry Pharmachem Co., Ltd. Gold
Tel
19157666807
Email
info@karrypharma.com
Shanghai Mixiu Chemical Co., Ltd. Gold
Tel
18101936766
Email
eileen@shmychem.com
Jinan Dexinjia Bio&Tech Co., Ltd Gold
Tel
0531-82371986 15269101859
Email
3276840968@qq.com